The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 2026 FDA Peptide Reclassification Purefico Medspa and Therapy FDA Approved Many New Drugs in 2022 That Will Improve the Lives of Patients and Consumers FDA FDA Removes 14 Peptides from Category 2 to Category 1 Mansi Hukmani posted on the topic LinkedIn